RxDoctor Payments Data

Edward Forster, MD

Family Medicine · Tallahassee, FLNPI 1215965058

Payments from drug & device makers

$6,529in general payments, 2019–2025

Across 338 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • AbbVie$878
  • Pfizer$603
  • Viiv Healthcare Company$566
  • Smith+Nephew$524
  • AstraZeneca$396
  • plus $2K from 35 others

What the payments were for

  • Speaking & faculty fees$1242%
  • Food & beverage$6,40598%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,529 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$5,402
Medicare patients
29
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$12,918
Esomeprazole Magnesium12$1,612
Atorvastatin Calcium86$1,250
Nifedipine ErNifedipine25$735
Hydrocortisone13$613
Gabapentin28$606
Celecoxib17$577
Omeprazole34$563
Levothyroxine Sodium31$490
Lisinopril36$467
Donepezil Hcl21$397
Metoprolol Tartrate40$379
Tamsulosin Hcl13$365
ClopidogrelClopidogrel Bisulfate12$362
Sertraline Hcl29$307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$603$12,91817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →